Patterns of grey and white matter changes differ between bulbar and limb onset amyotrophic lateral sclerosis.
Amyotrophic lateral sclerosis
Bulbar-onset
D50 model
Limb-onset
Tract–based spatial statistics
Voxel-based morphometry
Journal
NeuroImage. Clinical
ISSN: 2213-1582
Titre abrégé: Neuroimage Clin
Pays: Netherlands
ID NLM: 101597070
Informations de publication
Date de publication:
2021
2021
Historique:
received:
05
01
2021
revised:
09
04
2021
accepted:
10
04
2021
pubmed:
27
4
2021
medline:
31
7
2021
entrez:
26
4
2021
Statut:
ppublish
Résumé
Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disease that is characterized by a high heterogeneity in patients' disease course. Patients with bulbar onset of symptoms (b-ALS) have a poorer prognosis than patients with limb onset (l-ALS). However, neuroimaging correlates of the assumed biological difference between b-ALS and l-ALS may have been obfuscated by patients' diversity in the disease course. We conducted Voxel-Based-Morphometry (VBM) and Tract-Based-Spatial-Statistics (TBSS) in a group of 76 ALS patients without clinically relevant cognitive deficits. The subgroups of 26 b-ALS and 52 l-ALS patients did not differ in terms of disease Phase or disease aggressiveness according to the D50 progression model. VBM analyses showed widespread ALS-related changes in grey and white matter, that were more pronounced for b-ALS. TBSS analyses revealed that b-ALS was predominantly characterized by frontal fractional anisotropy decreases. This demonstrates a higher degree of neurodegenerative burden for the group of b-ALS patients in comparison to l-ALS. Correspondingly, higher bulbar symptom burden was associated with right-temporal and inferior-frontal grey matter density decreases as well as fractional anisotropy decreases in inter-hemispheric and long association tracts. Contrasts between patients in Phase I and Phase II further revealed that b-ALS was characterized by an early cortical pathology and showed a spread only outside primary motor regions to frontal and temporal areas. In contrast, l-ALS showed ongoing structural integrity loss within primary motor-regions until Phase II. We therefore provide a strong rationale to treat both onset types of disease separately in ALS studies.
Identifiants
pubmed: 33901988
pii: S2213-1582(21)00118-2
doi: 10.1016/j.nicl.2021.102674
pmc: PMC8099783
pii:
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
102674Informations de copyright
Copyright © 2021 The Author(s). Published by Elsevier Inc. All rights reserved.
Références
Amyotroph Lateral Scler Frontotemporal Degener. 2014 Mar;15(1-2):9-14
pubmed: 23781974
Nat Rev Neurol. 2013 Dec;9(12):708-14
pubmed: 24217521
Amyotroph Lateral Scler Frontotemporal Degener. 2019 Aug;20(5-6):385-395
pubmed: 31088163
Neurology. 2017 Jun 13;88(24):2302-2309
pubmed: 28500227
Neurology. 2007 Feb 20;68(8):600-2
pubmed: 17310031
J Neurol. 2017 Nov;264(11):2224-2231
pubmed: 28914354
J Neurol Neurosurg Psychiatry. 2017 Nov;88(11):917-924
pubmed: 28710326
PLoS One. 2015 Mar 20;10(3):e0119045
pubmed: 25793718
J Neurol. 2012 Sep;259(9):1848-59
pubmed: 22349938
J Clin Med. 2020 Sep 05;9(9):
pubmed: 32899481
Muscle Nerve. 2009 Aug;40(2):297-304
pubmed: 19609920
Health Qual Life Outcomes. 2020 May 1;18(1):117
pubmed: 32357946
Amyotroph Lateral Scler Frontotemporal Degener. 2014 Jun;15(3-4):216-25
pubmed: 24555884
Amyotroph Lateral Scler Other Motor Neuron Disord. 2005 Dec;6(4):213-20
pubmed: 16319024
Neuroimage. 2009 Jan 1;44(1):83-98
pubmed: 18501637
J Neurol Sci. 1999 Oct 31;169(1-2):13-21
pubmed: 10540002
J Neurol Neurosurg Psychiatry. 2015 Jan;86(1):38-44
pubmed: 24336810
J Neurol Neurosurg Psychiatry. 2018 Jan;89(1):53-60
pubmed: 29054917
Neuroimage Clin. 2020;25:102094
pubmed: 31896467
J Neurol. 2013 Nov;260(11):2856-64
pubmed: 23996101
Amyotroph Lateral Scler. 2007 Dec;8(6):343-7
pubmed: 18033592
Neuroimage. 2014 May 15;92:381-97
pubmed: 24530839
Hum Brain Mapp. 2021 Feb 15;42(3):737-752
pubmed: 33103324
Sci Rep. 2019 Dec 27;9(1):20059
pubmed: 31882886
Neuroimage. 2018 Apr 15;170:400-411
pubmed: 28213119
Neuroimage Clin. 2017 Jan 24;14:269-276
pubmed: 28203530
Amyotroph Lateral Scler Frontotemporal Degener. 2013 Dec;14(7-8):638-9
pubmed: 23859502
Amyotroph Lateral Scler Other Motor Neuron Disord. 2000 Dec;1(5):293-9
pubmed: 11464847
Cochrane Database Syst Rev. 2016 Jan 13;(1):CD011145
pubmed: 26760674
Neurology. 2000 Dec 12;55(11):1621-6
pubmed: 11113214
J Neurol. 2017 Jan;264(1):54-63
pubmed: 27778156
Neurologist. 2004 Sep;10(5):235-49
pubmed: 15335441
Ann Neurol. 2014 Nov;76(5):643-57
pubmed: 25223628
PLoS One. 2018 Apr 16;13(4):e0195821
pubmed: 29659621
Neurology. 2020 Jun 16;94(24):e2592-e2604
pubmed: 32414878
PLoS One. 2014 Aug 18;9(8):e104894
pubmed: 25133577
PLoS One. 2017 Jan 17;12(1):e0168424
pubmed: 28095425
J Comp Neurol. 1997 Dec 8;389(1):34-48
pubmed: 9390758
Amyotroph Lateral Scler Frontotemporal Degener. 2015;16(7-8):524-9
pubmed: 26402254
PLoS One. 2009 Sep 22;4(9):e7107
pubmed: 19771164
J Neurol Neurosurg Psychiatry. 2013 Jul;84(7):766-73
pubmed: 23085933
J Neurophysiol. 2004 Aug;92(2):1153-64
pubmed: 15056683
Clin Neurol Neurosurg. 2013 Aug;115(8):1281-7
pubmed: 23266262
PLoS One. 2017 Jun 2;12(6):e0178371
pubmed: 28575122
Brain. 2012 Mar;135(Pt 3):847-52
pubmed: 22271664
Brain. 2011 Apr;134(Pt 4):1211-28
pubmed: 21362631
J Neurol. 2014 Oct;261(10):1961-7
pubmed: 25059391
J Neurol Neurosurg Psychiatry. 2017 May;88(5):369-370
pubmed: 27913627
Amyotroph Lateral Scler Frontotemporal Degener. 2015 Mar;16(1-2):16-23
pubmed: 25292386
Hum Brain Mapp. 2007 Dec;28(12):1430-8
pubmed: 17370339
Lancet Neurol. 2018 May;17(5):423-433
pubmed: 29598923
J Neuroradiol. 2018 Feb;45(1):41-48
pubmed: 28802959
AJNR Am J Neuroradiol. 2012 Jun;33(6):1102-8
pubmed: 22300932
Cereb Cortex. 2016 Aug;26(8):3508-26
pubmed: 27230218
Amyotroph Lateral Scler. 2009 Feb;10(1):47-52
pubmed: 18622772
Neuroimage Clin. 2018 Apr 04;19:122-129
pubmed: 30035009
Hum Brain Mapp. 2009 Nov;30(11):3657-75
pubmed: 19404990
Neuroimage. 2002 Nov;17(3):1429-36
pubmed: 12414282
Neurol Sci. 2005 Jun;26(2):108-16
pubmed: 15995827